Analysis of Trump’s ‘Most Favoured Nation’ Executive Order on drug pricing, its global impact, price convergence aims, and ...

Despite substantial medical advancements that have transformed HIV into a manageable chronic condition for individuals, the ...

OHE submission to the UK Parliamentary Inquiry on an Ageing Society urges UK policy to focus on healthy ageing, adult ...

Professor Rosanna Tarricone is Associate Dean at SDA Bocconi School of Management and Associate Professor in Health Policy at Bocconi University, Department of Social and Political Science, Milan. Her ...

Kiran Bhatti joined OHE in March 2025 as a Business Executive. She holds an MBA Master of Business Administration degree. She is a finance professional with over 18 years’ experience in business ...

Meindert is a highly respected expert in the field of Health Technology Assessment (HTA) with more than 25 years’ experience in the field. Before starting as an independent advisor, Meindert was ...

Earlier this week, President Donald Trump signed an Executive Order to bring the prices Americans and U.S taxpayers pay for prescription drugs in line with those paid by similar nations. “President ...

Long-acting (LA) therapies represent a significant innovation in pharmaceutical development by offering a sustained drug effect with reduced administration frequency. Realising the potential value of ...

The glucagon-like peptide-1 (GLP-1) receptor agonist market is experiencing rapid growth, with more than 150 drug candidates currently in development as reported by Research & Markets, 2025. These ...

In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Angela Kairu and Edwine Barasa of the KEMRI Wellcome Trust Research Programme, and Paul Oyalo ...